• Halozyme to Present at Upcoming Investor Conferences

    16 days ago - By San Diego Biotechnology

    SAN DIEGO: SAN DIEGO, Nov. 18, 2021 /PRNewswire/ - Halozyme Therapeutics, Inc. today announced that it will participate at the following investor conferences: 33rd Annual Piper Sandler Virtual Healthcare Conference, Elaine Sun, senior vice president and chief financial officer, will represent the company in an on-demand, pre-recorded fireside...
    Read more ...

     

  • BioVaxys Chief Medical Officer David Berd, MD, Invited by Editorial Board of Therapeutic Advances in Vaccines and Immunotherapy to Submit a Review Article on Haptenized Protein Vaccine Platform

    16 days ago - By San Diego Biotechnology

    VANCOUVER, BC: VANCOUVER, BC, Nov. 18, 2021 /PRNewswire/ - BioVaxys Technology Corp. , , , a clinical-stage immunotherapy company, is pleased to announce that its Chief Medical Officer David Berd, MD, has been invited by the Editorial Board of Therapeutic Advances in Vaccines and...
    Read more ...

     

  • Kintara Presents Updates on Two Phase 2 Clinical Studies at the 2021 Society for Neuro-oncology Annual Meeting

    16 days ago - By San Diego Biotechnology

    SAN DIEGO: SAN DIEGO, Nov. 18, 2021 /PRNewswire/ - Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced data from two scientific posters for its Phase 2 clinical studies of VAL-083, the Company's lead compound...
    Read more ...

     

  • Heron Therapeutics Announces Submission of HTX-019 NDA for the Prevention of Postoperative Nausea and Vomiting to FDA

    16 days ago - By San Diego Biotechnology

    SAN DIEGO: SAN DIEGO, Nov. 18, 2021 /PRNewswire/ - Heron Therapeutics, Inc. , a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced the submission of its New Drug Application to...
    Read more ...